Amylyx Pharmaceuticals Announces FDA Acceptance and Priority

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

United States , Massachusetts , Phoenix , Arizona , Cambridge , Cambridgeshire , United Kingdom , Canada , Spaulding Rehabilitation Hospital , Tammy Sarnelli , Becky Gohsler , Justin Klee , Seanm Healey , Sabrina Paganoni , Joshua Cohen , Linkedin , Amylyx Pharmaceuticals Inc , Twitter , Global Head Of Regulatory Affairs Amylyx , Leandrop Rizzuto Foundation , Drug Administration , Harvard Medical School , Exchange Commission , Amylyx Pharmaceuticals , Treatment Research Initiative To Cure , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , Access Program , New Drug Application , Priority Review , Prescription Drug User Fee Act , Expanded Access Program , Global Head , Regulatory Affairs , Rating Scale , New England Journal , Merit Cudkowicz , Massachusetts General Hospital , Julieanne Dorn Professor , Harvard Medical , Treatment Research Initiative , Assistant Professor , Spaulding Rehabilitation , Application Reviews , Marketing Authorization Application , Medicinal Products , Human Use , Rating Scale Revised , Bucket Challenge , Amylyx Phase , United States Securities , Business Wire , Coronavirus Pandemic , Health , Business , Europe , Clinical Trials ,